Rationale and design of a clinical trial of a reduced dosing schedule for the nonavalent human papillomavirus vaccine in women living with HIV: The NOVA-HIV study.
Virtually all cases of cervical cancer are caused by human papillomavirus (HPV). Women and people with a cervix living with HIV (women with HIV) are disproportionately impacted by cervical cancer; they experience higher rates of HPV infection and increased susceptibility to persistent HPV infection than women without H...